Breaking News Instant updates and real-time market news.

KRNT

Kornit Digital

$31.55 /

+0.41 (+1.32%)

08:28
07/06/22
07/06
08:28
07/06/22
08:28

Craig-Hallum downgrades Kornit Digital to Hold, lowers price target to $26

As previously reported, Craig-Hallum analyst Greg Palm downgraded Kornit Digital to Hold from Buy with a price target of $26, down from $54. The analyst notes Kornit reported "surprisingly poor" Q2 results, with a sizable revenue and profitability miss. Even more puzzling was the delta between those results and expectations given management's generally bullish tone in early to mid-June at several conferences, Palm adds. While he attributes some of the shortfall to be overall macro-related, he also believes a significant portion of the miss was associated with the pushout of systems to a global strategic customer. At this point, commentary suggests an overall lack of visibility, something that will likely impact investor sentiment in the near-term, Palm argues. While Q2 results are likely to be the trough, and he expects improvements in profitability in the second half of the year, the analyst thinks it's appropriate to step to the sidelines for the time being.

  • 19

    Nov

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks
Rapid Micro Biosystems announces restructuring plan with 20% workforce reduction » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

The Company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Leap Therapeutics reports Q2 EPS (15c), consensus (10c) » 07:04
08/12/22
08/12
07:04
08/12/22
07:04
LPTX

Leap Therapeutics

$1.32 /

+0.15 (+12.82%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

06/06/22 Piper Sandler
Piper says Leap's DKN-01 combo showed 'interesting early signal of activity'
05/27/22 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
01/23/22 Piper Sandler
Piper ups Leap Therapeutics target to $6 following DKN-01's ASCO GI Update
12/30/21 Mizuho
Mizuho announces top oncology stock picks for 2022
LPTX Leap Therapeutics
$1.32 /

+0.15 (+12.82%)

  • 22
    Sep
Earnings
Rapid Micro Biosystems lowers FY22 revenue view to at least $17M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Consensus $28.01M. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Humacyte reports Q2 EPS 35c, consensus (22c) » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HUMA

Humacyte

$4.38 /

+0.89 (+25.50%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

07/18/22 BTIG
Humacyte price target lowered to $10 from $12 at BTIG
05/15/22 Piper Sandler
Humacyte downgraded to Underweight from Overweight at Piper Sandler
03/29/22 Piper Sandler
Humacyte price target lowered to $10 from $17 at Piper Sandler
10/29/21 Cowen
Humacyte initiated with an Outperform at Cowen
HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

HUMA Humacyte
$4.38 /

+0.89 (+25.50%)

Earnings
Ocuphire Pharma reports Q2 EPS (25c) vs (52c) last year » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
OCUP

Ocuphire Pharma

$2.76 /

+0.405 (+17.23%)

"Ocuphire has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

05/19/22 Alliance Global Partners
Alliance Global Partners says Ocuphire's Nyxol trial run 'remarkable'
11/24/21 H.C. Wainwright
Ocuphire Pharma initiated with a Buy at H.C. Wainwright
10/06/21 Spartan Capital
Ocuphire Pharma initiated with a Buy at Spartan Capital
OCUP Ocuphire Pharma
$2.76 /

+0.405 (+17.23%)

Downgrade
Powszechny Zaklad Ubezpieczen downgraded to Neutral from Buy at Citi » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
PWZYF

Powszechny Zaklad Ubezpieczen

$7.69 /

+ (+0.00%)

Citi analyst Andrzej…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWZYF Powszechny Zaklad Ubezpieczen
$7.69 /

+ (+0.00%)

06/21/22 JPMorgan
Powszechny Zaklad Ubezpieczen price target lowered to PLN 46.90 at JPMorgan
05/10/22 JPMorgan
PZU price target lowered to PLN 49.25 from PLN 52.75 at JPMorgan
12/14/21 JPMorgan
Powszechny Zaklad Ubezpieczen price target raised to PLN 152.75 at JPMorgan
Earnings
Honest Company sees FY22 revenue growth flat, consensus $318.65M » 07:03
08/12/22
08/12
07:03
08/12/22
07:03
HNST

Honest Company

$3.83 /

+0.005 (+0.13%)

Revenue outlook reflects…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

Hot Stocks
Broadridge raises annual dividend 13% to $2.90 from $2.56 per share » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

On August 11,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Earnings
Maverix Metals reports Q2 adjusted EPS 3c, consensus 3c » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
MMX

Maverix Metals

$4.06 /

-0.07 (-1.69%)

Reports Q2 revenue $14.2M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

07/20/22 Stifel
Maverix Metals price target lowered to C$8.25 from C$8.75 at Stifel
04/20/22 National Bank
Maverix Metals price target raised to C$7 from C$6.75 at National Bank
04/20/22 Raymond James
Maverix Metals price target raised to C$8.75 from C$8 at Raymond James
01/18/22 Raymond James
Maverix Metals price target lowered to C$8 from C$8.50 at Raymond James
MMX Maverix Metals
$4.06 /

-0.07 (-1.69%)

Earnings
Rapid Micro Biosystems reports Q2 EPS (31c) vs. ($20.01) last year » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Honest Company reports Q2 EPS (11c), consensus (8c) » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
HNST

Honest Company

$3.83 /

+0.005 (+0.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

06/09/22 Loop Capital
Loop Capital cuts Honest Company to Hold amid pressure reported in mass retail
06/09/22 Loop Capital
Honest Company downgraded to Hold from Buy at Loop Capital
05/16/22 Loop Capital
Honest Company price target lowered to $5 from $8 at Loop Capital
03/28/22 Citi
Honest Company shares look 'awfully cheap' after selloff, says Citi
HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

HNST Honest Company
$3.83 /

+0.005 (+0.13%)

Recommendations
Rivian Automotive's liqudity can last through most of FY23, says Morgan Stanley » 07:02
08/12/22
08/12
07:02
08/12/22
07:02
RIVN

Rivian Automotive

$38.91 /

+1.475 (+3.94%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

06:44 Today Mizuho
Rivian Automotive price target lowered to $65 from $70 at Mizuho
07/18/22 Deutsche Bank
Rivian Automotive price target lowered to $46 from $69 at Deutsche Bank
07/13/22 Canaccord
Rivian Automotive initiated with a Buy at Canaccord
07/08/22 Wedbush
Wedbush ups Rivian target, says story 'starting to turn the corner'
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

  • 10
    Nov
RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

RIVN Rivian Automotive
$38.91 /

+1.475 (+3.94%)

Earnings
Broadridge sees FY23 adjusted EPS growth 7%-11%, consensus $7.06 » 07:01
08/12/22
08/12
07:01
08/12/22
07:01
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

Sees FY23 recurring…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Earnings
Broadridge reports Q4 adjusted EPS $2.65, consensus $2.62 » 07:00
08/12/22
08/12
07:00
08/12/22
07:00
BR

Broadridge

$169.66 /

-0.745 (-0.44%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BR Broadridge
$169.66 /

-0.745 (-0.44%)

BR Broadridge
$169.66 /

-0.745 (-0.44%)

08/17/21 JPMorgan
Broadridge price target raised to $197 from $181 at JPMorgan
08/16/21 DA Davidson
Broadridge price target raised to $158 from $152 at DA Davidson
08/13/21 JPMorgan
Broadridge assumed with an Overweight at JPMorgan
BR Broadridge
$169.66 /

-0.745 (-0.44%)

Downgrade
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research » 07:00
08/12/22
08/12
07:00
08/12/22
07:00
ALGT

Allegiant Travel

$107.03 /

-0.12 (-0.11%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

08/10/22 Barclays
Allegiant Travel price target lowered to $150 from $180 at Barclays
08/04/22 Deutsche Bank
Allegiant Travel price target lowered to $190 from $245 at Deutsche Bank
07/26/22 Susquehanna
Allegiant Travel negative reveal suggests price sensitivity, says Susquehanna
07/12/22 Susquehanna
Allegiant Travel price target lowered to $140 from $185 at Susquehanna
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

Recommendations
Illumina price target lowered to $200 from $220 at Citi » 06:59
08/12/22
08/12
06:59
08/12/22
06:59
ILMN

Illumina

$227.64 /

+0.44 (+0.19%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

06:36 Today Baird
Illumina price target lowered to $215 from $306 at Baird
08/11/22 Piper Sandler
Illumina miss 'surprising' given backlog, says Piper Sandler
07/14/22 Canaccord
Illumina merger challenge not reflection of merits, says Canaccord
07/13/22 Piper Sandler
Illumina uncertainty over Grail continues with ruling, says Piper Sandler
ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

ILMN Illumina
$227.64 /

+0.44 (+0.19%)

Recommendations
Sight Sciences price target lowered to $14 from $17 at Morgan Stanley » 06:59
08/12/22
08/12
06:59
08/12/22
06:59
SGHT

Sight Sciences

$9.84 /

-0.29 (-2.86%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGHT Sight Sciences
$9.84 /

-0.29 (-2.86%)

SGHT Sight Sciences
$9.84 /

-0.29 (-2.86%)

08/11/22 Piper Sandler
Sight Sciences price target lowered to $15 from $17 at Piper Sandler
07/25/22 Stifel
Sight Sciences initiated with a Hold at Stifel
05/11/22 Piper Sandler
Sight Sciences price target lowered to $17 from $23 at Piper Sandler
04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
SGHT Sight Sciences
$9.84 /

-0.29 (-2.86%)

SGHT Sight Sciences
$9.84 /

-0.29 (-2.86%)

SGHT Sight Sciences
$9.84 /

-0.29 (-2.86%)

Hot Stocks
Brookfield Business Partners to renew normal course issuer bid » 06:58
08/12/22
08/12
06:58
08/12/22
06:58
BBU

Brookfield Business Partners

$25.00 /

-0.63 (-2.46%)

Brookfield Business…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBU Brookfield Business Partners
$25.00 /

-0.63 (-2.46%)

BBU Brookfield Business Partners
$25.00 /

-0.63 (-2.46%)

08/08/22 RBC Capital
Brookfield Business Partners price target raised to $34 from $31 at RBC Capital
03/15/22 National Bank
Brookfield Business Partners price target lowered to $39 from $68 at National Bank
02/07/22 Desjardins
Brookfield Business Partners price target raised to $59 from $57 at Desjardins
BBU Brookfield Business Partners
$25.00 /

-0.63 (-2.46%)

BBU Brookfield Business Partners
$25.00 /

-0.63 (-2.46%)

Hot Stocks
WeTrade to sell monkeypox virus test kits, antigen tests for $50M » 06:57
08/12/22
08/12
06:57
08/12/22
06:57
WETG

WeTrade

$14.08 /

-1.32 (-8.57%)

WeTrade announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WETG WeTrade
$14.08 /

-1.32 (-8.57%)

  • 19
    Jul
Recommendations
Cytokinetics price target raised to $15 from $11 at Morgan Stanley » 06:56
08/12/22
08/12
06:56
08/12/22
06:56
CYTK

Cytokinetics

$49.47 /

-3.26 (-6.18%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$49.47 /

-3.26 (-6.18%)

CYTK Cytokinetics
$49.47 /

-3.26 (-6.18%)

08/05/22 Raymond James
Cytokinetics price target raised to $63 from $54 at Raymond James
06/30/22 Piper Sandler
Piper says Cytokinetics pullback due to Street 'misunderstanding' financing
06/17/22 H.C. Wainwright
H.C. Wainwright says confidence in approval of Cytokinetics' omecamtiv unchanged
06/17/22 Piper Sandler
Cytokinetics PDUDA extension 'not a big deal,' says Piper Sandler
CYTK Cytokinetics
$49.47 /

-3.26 (-6.18%)

CYTK Cytokinetics
$49.47 /

-3.26 (-6.18%)

Hot Stocks
Avient to sell distribution business for $950M in cash » 06:55
08/12/22
08/12
06:55
08/12/22
06:55
AVNT

Avient

$44.93 /

-0.84 (-1.84%)

Avient announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVNT Avient
$44.93 /

-0.84 (-1.84%)

AVNT Avient
$44.93 /

-0.84 (-1.84%)

07/27/22 Stifel
Avient price target lowered to $70 from $76 at Stifel
07/27/22 Baird
Avient price target lowered to $56 from $63 at Baird
07/07/22 Wells Fargo
Avient price target lowered to $53 from $65 at Wells Fargo
06/28/22 Jefferies
Avient price target lowered to $51 from $67 at Jefferies
AVNT Avient
$44.93 /

-0.84 (-1.84%)

Earnings
PLx Pharma reports Q2 EPS (52c), consensus (56c) » 06:55
08/12/22
08/12
06:55
08/12/22
06:55
PLXP

PLx Pharma

$2.59 /

+0.015 (+0.58%)

Reports Q2 revenue $0.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

03/15/22 BWS Financial
BWS drops coverage of PLx Pharma, says off Amazon again
12/07/21 Raymond James
Raymond James upgrades PLx Pharma on 'compelling entry point'
12/07/21 Raymond James
PLx Pharma upgraded to Outperform from Market Perform at Raymond James
11/12/21 JMP Securities
PLx Pharma reported strong quarter for Vazalore, says JMP Securities
PLXP PLx Pharma
$2.59 /

+0.015 (+0.58%)

Recommendations
Morgan Advanced Materials price target lowered to 395 GBp from 440 GBp at Jefferies » 06:53
08/12/22
08/12
06:53
08/12/22
06:53
MCRUF

Morgan Advanced Materials

$3.50 /

+ (+0.00%)

Jefferies analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCRUF Morgan Advanced Materials
$3.50 /

+ (+0.00%)

08/01/22 RBC Capital
Morgan Advanced Materials price target raised to 330 GBp at RBC Capital
01/19/22 Berenberg
Morgan Advanced Materials upgraded to Buy from Hold at Berenberg
11/09/21 Citi
Morgan Advanced Materials price target raised to 460 GBp from 450 GBp at Citi
Recommendations
Viavi price target lowered to $18 from $20 at Susquehanna » 06:52
08/12/22
08/12
06:52
08/12/22
06:52
VIAV

Viavi

$15.26 /

-0.035 (-0.23%)

Susquehanna analyst Mehdi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIAV Viavi
$15.26 /

-0.035 (-0.23%)

VIAV Viavi
$15.26 /

-0.035 (-0.23%)

07/19/22 Needham
Viavi cut to Hold at Needham on larger exposure to EMEA, iPhone sales pressure
07/19/22 Needham
Viavi downgraded to Hold from Buy at Needham
07/14/22 JPMorgan
Viavi price target lowered to $15 from $18 at JPMorgan
02/04/22 B. Riley
Viavi price target raised to $21 from $19.50 at B. Riley
VIAV Viavi
$15.26 /

-0.035 (-0.23%)

VIAV Viavi
$15.26 /

-0.035 (-0.23%)

Recommendations
Expedia price target lowered to $115 from $145 at Susquehanna » 06:51
08/12/22
08/12
06:51
08/12/22
06:51
EXPE

Expedia

$110.12 /

+0.895 (+0.82%)

Susquehanna analyst Shyam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPE Expedia
$110.12 /

+0.895 (+0.82%)

EXPE Expedia
$110.12 /

+0.895 (+0.82%)

08/05/22 Mizuho
Expedia price target lowered to $132 from $172 at Mizuho
08/05/22 Barclays
Expedia price target raised to $161 from $157 at Barclays
08/01/22 Deutsche Bank
Expedia price target lowered to $130 from $235 at Deutsche Bank
07/14/22 Truist
Expedia price target lowered to $185 from $240 at Truist
EXPE Expedia
$110.12 /

+0.895 (+0.82%)

  • 10
    Nov
EXPE Expedia
$110.12 /

+0.895 (+0.82%)

EXPE Expedia
$110.12 /

+0.895 (+0.82%)

EXPE Expedia
$110.12 /

+0.895 (+0.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.